News Overview

SBI Life Insurance Company has entered into an agreement on 23 November 2022 in relation to an initial investment of Rs 50,000 in the seed equity capital of the proposed Joint Venture (JV) of Indian Oil Corporation (IOCL) and Chennai Petroleum Corporation (CPCL) (target entity) (to be incorporated). The target entity is a 9 MMTPA refinery at Nagapattinam, Tamil Nadu in which IOCL and CPCL […]

By Everest Group

IndusInd Bank has allotted 25,348 equity shares under ESOP on 24 November 2022. Powered by Capital Market – Live News

On private placement basis

PVR has opened a 12 screen superlex in city of Kerala at Lulu Mall, Thiruvananthapuram. The cinema is equipped with advanced Dolby 7.1 immersive audio and Next-Gen 3D technology to provide an unparalleled captivating and immersive experience and plush recliner seats for enhanced comfort and 2K RGB+ Laser projectors that deliver ultra-high resolution. With this launch, PVR now operates the largest multiplex network with 876 […]

KIOCL announced that the operations of Pellet Plant Unit of the Company at Mangalore have been restarted today i.e., with effect from 24 November 2022. Powered by Capital Market – Live News

The Singapore stock market finished session lower on Thursday, 24 November 2022, even as regional indices rose after minutes from the US Federal Reserve signalled it could slow its rate hikes, weighed down by losses in financials and consumer goods stocks. At closing bell, the Straits Times Index (STI) index was down 3.11 points or 0.1% to 3,252.88 after trading between 3,250.15 and 3,273.43. Volume […]

Biocon announced that with reference to the proposed acquisition of biosimilars assets of Viatris Inc., by Biocon Biologics (BBL), subsidiary of Biocon, BBL has allotted equity shares to Biocon for an amount of Rs. 2,205.63 crore (~US$ 270 Million) on 23 November 2022. Post allotment, Biocons stake in BBL will be 88.85%. Powered by Capital Market – Live News

Gland Pharma has allotted 1,800 Equity shares of Re.1/- each of the Company, fully paid up, on 24 November 2022 to employee(s) on exercise of their Stock Options pursuant to Gland Pharma Employee Stock Options Scheme, 2019. Consequently, the issued, subscribed and paid-up share capital of the Company stands increased to Rs. 164,690,223 /- comprising of 164,690,223 Equity shares of face value Re.1/- eachPowered by […]

With effect from 25 November 2022